Literature DB >> 2867926

Changes in gamma-aminobutyrate, glutamate, aspartate, glycine, and taurine contents in the striatum after unilateral nigrostriatal lesions in rats.

Y Tanaka, K Niijima, Y Mizuno, M Yoshida.   

Abstract

Contents of five amino acids (gamma-aminobutyrate (GABA), glutamate, aspartate, glycine, and taurine) were assayed in the rat striatum in which nigrostriatal pathways were unilaterally destroyed by 6-hydroxydopamine. GABA content in the operated side was significantly increased 1 month after the surgery compared with that in the nonoperated side. Contents of four other amino acids assayed did not change significantly. Among possible mechanisms for this elevation we postulated that sprouting of the GABAergic terminals in the striatum would be most probable.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2867926     DOI: 10.1016/0014-4886(86)90066-x

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  10 in total

1.  Electrophysiological and morphological evidence for a GABAergic nigrostriatal pathway.

Authors:  M Rodríguez; T González-Hernández
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

2.  Region specific regulation of glutamic acid decarboxylase mRNA expression by dopamine neurons in rat brain.

Authors:  N Lindefors; S Brene; M Herrera-Marschitz; H Persson
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

3.  Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.

Authors:  N Lindefors; E Brodin; U Tossman; J Segovia; U Ungerstedt
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

4.  Consequences of developmental exposure to concentrated ambient ultrafine particle air pollution combined with the adult paraquat and maneb model of the Parkinson's disease phenotype in male mice.

Authors:  Joshua L Allen; Xiufang Liu; Douglas Weston; Katherine Conrad; Günter Oberdörster; Deborah A Cory-Slechta
Journal:  Neurotoxicology       Date:  2014-01-30       Impact factor: 4.294

5.  L-DOPA Reverses the Increased Free Amino Acids Tissue Levels Induced by Dopamine Depletion and Rises GABA and Tyrosine in the Striatum.

Authors:  Oscar Solís; Patricia García-Sanz; Antonio S Herranz; María-José Asensio; Rosario Moratalla
Journal:  Neurotox Res       Date:  2016-03-10       Impact factor: 3.911

Review 6.  The effect of striatal dopamine depletion on striatal and cortical glutamate: A mini-review.

Authors:  Fernando Caravaggio; Shinichiro Nakajima; Eric Plitman; Philip Gerretsen; Jun Ku Chung; Yusuke Iwata; Ariel Graff-Guerrero
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-09-01       Impact factor: 5.067

7.  Time-course of SKF-81297-induced increase in glutamic acid decarboxylase 65 and 67 mRNA levels in striatonigral neurons and decrease in GABA(A) receptor alpha1 subunit mRNA levels in the substantia nigra, pars reticulata, in adult rats with a unilateral 6-hydroxydopamine lesion.

Authors:  N Yamamoto; J-J Soghomonian
Journal:  Neuroscience       Date:  2008-04-16       Impact factor: 3.590

8.  Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS.

Authors:  Uzay E Emir; Paul J Tuite; Gülin Öz
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

9.  Sleep-State Dependent Alterations in Brain Functional Connectivity under Urethane Anesthesia in a Rat Model of Early-Stage Parkinson's Disease.

Authors:  Ekaterina Zhurakovskaya; Juuso Leikas; Tiina Pirttimäki; Francesc Casas Mon; Mikko Gynther; Rubin Aliev; Tomi Rantamäki; Heikki Tanila; Markus M Forsberg; Olli Gröhn; Jaakko Paasonen; Aaro J Jalkanen
Journal:  eNeuro       Date:  2019-02-26

Review 10.  TGF-β/Smad3 Signalling Modulates GABA Neurotransmission: Implications in Parkinson's Disease.

Authors:  Mª Dolores Muñoz; Nerea de la Fuente; Amelia Sánchez-Capelo
Journal:  Int J Mol Sci       Date:  2020-01-16       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.